Abstract
Thyroid metastasis are rare and represent less than 4% of malignant thyroid tumors in clinical series. They can develop many years after diagnosis of the primary tumor. We report a case of thyroid metastasis of adrenocortical carcinoma, 41 years after the diagnosis of the primary tumor. Such a long latent interval is exceptional. To our knowledge, this is the first case published. Based on current literature, we offer a brief review on thyroid metastasis and differential diagnosis of thyroid gland clear cell neoplasm.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adenocarcinoma, Clear Cell / drug therapy
-
Adenocarcinoma, Clear Cell / metabolism
-
Adenocarcinoma, Clear Cell / radiotherapy
-
Adenocarcinoma, Clear Cell / secondary*
-
Adenocarcinoma, Clear Cell / surgery
-
Adrenal Cortex Neoplasms / radiotherapy
-
Adrenal Cortex Neoplasms / secondary*
-
Adrenal Cortex Neoplasms / surgery
-
Adrenalectomy
-
Antineoplastic Agents / therapeutic use
-
Biomarkers, Tumor / analysis
-
Combined Modality Therapy
-
Dehydroepiandrosterone Sulfate / urine
-
Humans
-
Hydrocortisone / urine
-
Kidney Neoplasms / chemistry
-
Kidney Neoplasms / pathology
-
Kidney Neoplasms / surgery
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / secondary
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / secondary
-
Male
-
Middle Aged
-
Mitotane / therapeutic use
-
Nephrectomy
-
Radiotherapy, Adjuvant
-
Thyroid Neoplasms / drug therapy
-
Thyroid Neoplasms / metabolism
-
Thyroid Neoplasms / secondary*
-
Thyroid Neoplasms / surgery
-
Thyroidectomy
-
Time Factors
Substances
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Dehydroepiandrosterone Sulfate
-
Mitotane
-
Hydrocortisone